Investigators conducted a meta-analysis of randomized controlled trials to assess the efficacy and safety of brolucizumab ...

In response to a report of foreign material found in a sealed vial, Alcon Laboratories has initiated a voluntary recall of ...

This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for. This series features experts in ophthalmology sharing their ...

Fixed-interval dosing in nAMD treatment generally outperforms as-needed regimens in maintaining visual acuity over time. Sozinibercept, targeting VEGF-C/D, shows promise in improving visual outcomes ...

Thelaziasis is a zoonotic ocular infection caused by Thelazia callipaeda, transmitted by Drosophilid flies, leading to symptoms from mild irritation to severe inflammation. Diagnosis requires ...

As 2024 comes to a close, we here at Ophthalmology Times and the greater Eye Care Network would like to thank you–the reader.

Deepinder Dhaliwal, MD, LAc, explores advancements in managing Fuchs endothelial corneal dystrophy, highlighting Descemet ...

Electrical stimulation therapy is being explored as a potential treatment to enhance neuroplasticity and improve visual ...

Alon Kahana, MD, PhD, discusses the role of interleukin-6 in thyroid eye disease and the potential of tourmaline Bio's IL-6 ...

Deepinder Dhaliwal, MD, LAc, discusses longterm outcomes of Descemet Stripping Only (DSO) for Fuchs dystrophy at NYU's ...

A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect ...